Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502695 · ClinicalTrials.gov registry record
A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 173
- Enrollment target
NCT02502695 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 173 participants.
The verdict
NCT02502695 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 173 participants
- Enrollment target
Study Summary
This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.
Interventions
- OTHER VATS-associated best practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02502695
The ClinicalTrials.gov registry entry for NCT02502695 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VATS-associated best practices is the first listed.
NCT02502695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02502695 about?
NCT02502695 is a clinical study titled "A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)". This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy ...
What is the current status of trial NCT02502695?
This trial is currently completed. The enrollment target is 173 participants. The study started on 2015-06. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02502695?
The interventions under investigation include: VATS-associated best practices (OTHER).
Who is sponsoring clinical trial NCT02502695?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.